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incidence between the two groups calculated by patient 
proportion. However, in separate, the rate of second-
ary adjacent fractures calculated by vertebral refracture 
number is significantly higher than non-adjacent levels 
in PVP/PKP group but no significant statistical differ-
ence was observed in conservative group. The time inter-
val of recompression after operative procedure was much 
shorter than that for comparison group (9.7 ± 17.8 versus 
22.4 ± 7.99 months, p = 0.017). In addition, older age, 
gender, fracture times, location of original fracture seg-
ment, the amount of cement, cement leakage, operation 
modality (PVP or PKP),and initial number of OVCFs were 
documented, but these were not the influencing factors in 
this study (p > 0.05).
Conclusions  Patients who had experienced PVP/PKP 
were not associated with an increased risk of recompres-
sion in new levels. However, recompression in new lev-
els of PVP/PKP group occurred much sooner than that of 
conservative group in the follow-up period. The incidence 
of new vertebral fractures observed at adjacent levels was 
substantially higher but no sooner than at distant levels 
in PVP/PKP group. No major risk factors involving new 
OVCFs have been found in this study and  augmentation 
for sandwich situation is not necessary.
Keywords Percutaneous vertebroplasty · Kyphoplasty · 
Adjacent fracture · Conservative treatment
Introduction
Since 1987, percutaneous vertebroplasty (PVP) and 
kyphoplasty (PKP) with polymethylmethacrylate (PMMA) 
augmentation have been highly advocated as treat-
ment techniques for osteoporotic vertebrate compression 
Abstract 
Study design A prospective clinical study assessing new 
vertebral compression fracture after previous treatment.
Objective The purpose of this study was to investigate the 
incidence and associated risk factors of new symptomatic 
osteoporotic vertebral compression fractures (OVCFs) in 
patients treated by percutaneous vertebroplasty (PVP) and 
kyphoplasty (PKP) versus conservative treatment, and to 
elucidate our findings.
Summary of background data There are a lot of reports 
concerning the feasibility and efficacy of this minimally 
invasive procedure compared with conservative treatment, 
especially in pain soothing. However, it is still unclear 
whether the risk of subsequent fracture has increased 
among operative treatment patients in the long term.
Methods From November 2005 to July 2009, 290 con-
secutive patients with 363 OVCFs were randomly selected 
for PVP/PKP or conservative treatment and evaluated with 
a mean follow-up of 49.4 months (36–80 months). Some 
parameters were characterized and statistically compared 
in this study. Telephone questionnaires, clinical reexamine, 
and plain radiographs were performed in the follow-up.
Results Thirty-one of 290 (10.7 %) patients had expe-
rienced 42 newly developed symptomatic secondary 
OVCFs. Among 169 operation (53.3 % vertebroplasty, 
46.7 % kyphoplasty) and 121 comparison patients, there 
is no significant statistical difference of new OVCFs 
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fractures (OVCFs) [1]. Although the overall satisfaction 
rate ranges between 70 and 90 %, and complication rate 
associated is reported to be very low, some authors have 
indicated that PVP/PKP increases the risk for subsequent 
vertebral fractures [2–5].
Multiple covariate analysis, such as patient character-
istics and procedural techniques, has been used to iden-
tify risk factors [6–7]. But it is still unclear as to what the 
exact relevant element is and whether such fractures are 
procedure-related or part of the natural course of osteo-
porosis. There also have been no reports to date of a large 
series of new vertebral fractures that developed within 
adjacent or nonadjacent levels comparing PVP/PKP and 
conservative treatment. In our original study, we pro-
spectively investigate the incidence of new symptomatic 
OVCFs in patients treated by PVP/PKP or conservative 
therapy and discuss the possible causative mechanism of 
refracture.
Materials and methods
Our study was performed at the Peking University First 
Hospital Orthopedics Department and approved by Institu-
tional Review Board. Herein we report our first hand data 
statistics regarding China mainland.
Study design
From November 2005 to July 2009, a total of 290 patients 
with 363 symptomatic OVCFs received treatment at our 
institution. Patients were randomized to one of three dif-
ferent treatments: percutaneous vertebroplasty (PVP) 
(n = 90), and kyphoplasty (PKP) (n = 79) and conserva-
tive treatment (CT) (n = 121). All patients underwent bone 
density examination before treatment and the extent of 
osteoporosis was not significantly different among them. 
The study was designed to investigate the incidence of rec-
ompression in adjacent or distant levels after conservative 
treatment compared with PVP/PKP and also to detect risk 
factors. The following were the inclusion criteria: symp-
tomatic OVCFs at first time with serious low back pain 
and a high signal in T2 MRI image, diagnosed by severe 
osteoporosis.
A surgeon at the outpatient ward blindly chose one of 
the three different treatment modalities to ensure similar 
pre-treatment age, symptoms, grade and level of spinal dis-
eases among the patients. One senior surgeon performed all 
the operations and another spine surgeon not involved with 
the surgeries analyzed the results.
No patients were lost to follow-up during the study. 
There were 181 women and 109 men and the average 
patient age at the time of treatment was 61.3 years (age 
range, 48–75 years). The average duration of follow-up was 
49.4 months (range 36–80 months).
Operation group
We performed operation in 217 vertebrae for 169 patients, 
53.3 % (90) with vertebroplasty and 46.7 % (79) with 
kyphoplasty. PVP/PKP was not performed in case of a 
severe spinal stenosis with infiltration of the posterior wall 
or with any neurological deficit, coagulopathy, infection, 
radicular syndrome, and some other contraindications. 
Patients who were treated for metastatic disease, corticos-
teroid-induced subsequent osteoporosis, vertebral heman-
gioma or treated in combination with surgery were also 
excluded. Since there is no selection bias in our institution 
regarding treatment with PVP or PKP, we combine them 
into one group as compared with conservative group.
Conservative group
The other 121 patients diagnosed by similar baseline char-
acteristics with PVP/PKP group received conservative 
treatment. The exclusion criteria were also the same with 
PVP/PKP group.
Surgical technique and clinical intervention
Every PVP/PKP-treated patient received local anesthesia 
and intravenous conscious sedation during the procedure. 
An 11-G bone marrow biopsy needle (REF T05E kyphx 
Osteo-Introducer System, kyphon Inc. Medtronic, Min-
nesota) was used to puncture the collapsed vertebral body 
through either side of the pedicles, and the needle advanced 
to the anterior third of the vertebral body under bi-plane 
fluoroscopic guidance (Arcardis Varic mobile X-ray sys-
tem, Siemens, Germany). After transpedicular positioning, 
the needles were exchanged over a guidewire for a working 
cannula (For PVP, we choose Kynefyc systems, Shanghai, 
China). For PKP, inflatable bone tamps (REF K02A, kyphx 
Xpander Inflatable Bone Tamp Kyphon, Medtronic, Min-
nesota) were then placed into the vertebral bodies unilater-
ally. A dedicated delivery system (REF F04B, kyphx Bone 
Filler Device, kyphon Inc. Medtronic, America) was used 
to inject the bone cement. In the case of “sandwich bod-
ies” (f.i. L2 and L4 to be treated), some intermediate verte-
bral bodies were prophylactically treated (Fig. 1). Usually 
pain was relieved almost immediately after the procedure: 
patients could mobilize themselves several hours later and 
no brace was needed. Overnight hospital stay was required 
and patients were discharged home the next day. Patients in 
the conservative group were offered pain medication, bed 
rest, a solf bi-valved body brace, and physiotherapy; the 
mean length hospital stay was 13.7 days.
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Fig. 1  a Sagittal T1, T2-weighted MR and plain images show T10, T12–L2 OVCF of a 73-year-old man treated by PKP in February, 2008. T11 
was treated prophylactically. b Ten months later, a new compression fracture at T6 was subjected to repeated PKP
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A series of anti-osteoporosis therapies were applied to treat 
osteoporosis and prevent refracture in both groups. The availa-
ble pharmacologic therapy included bisphosphonates, calcium 
carbonate particles, salmon calcitonin injection, and calci-
triol soft capsules, which were advised to be taken at least for 
2 years. Tobacco cessation, restrained alcohol consumption, 
weight-bearing exercise, and fall prevention strategy were also 
required to be complied with in the follow-up period.
Radiological and clinical assessment
All the patients had undergone radiography and MRI of 
the lumbar spine before treatment to diagnose the sympto-
matic OVCFs and to evaluate the status of an adjacent seg-
ment. For validation, measurements were performed twice 
by three independent observers, two experienced spine sur-
geons and one radiologist, to ensure randomization of treat-
ment method. Radiographs included standing anteropos-
terior and lateral views. The same radiographs and MRI 
were repeated at 6 months and at yearly intervals until the 
last follow-up session. If high T2 MRI signal was observed 
in new segments and A VAS score >7 was identified, new 
symptomatic OVCFs were defined excluding other diseases, 
so as to refracture of the same index segment. In this study, 
we only recorded and analyzed the symptomatic OVCFs.
Statistical analysis
We performed statistical analysis with SPSS for Windows 
Version 16.0 (SPSS, Chicago, IL, USA). Chi square test 
was used to compare the incidence and patient propor-
tions. The paired t test was used for evaluation of differ-
ences between adjacent and nonadjacent segments. Data 
are expressed as mean ± SD. A p value of <0.05 was con-
sidered statistically significant.
Results
No major adverse events were observed during procedure 
or follow-up period. 87.6 % patients of PVP/PKP group 
returned to their normal lives 1 week after operation and 
59.2 % patients of conservative group exercise to their 
regular level 2 months later. In total, 31 of 290 (10.7 %) 
patients returned with 42 new OVCFs (Table 1). 14 indi-
viduals (5 males, 9 females) were initially treated by sur-
gical technique (PVP 9, PKP 5) and 17 ones (7 males, 10 
females) were from conservative group. 25 patients were 
subjected to repeated PVP/PKP and the other six patients 
were successfully managed by conservative care. Of these 
newly documented fractures, 14 (34.2 %) involved adjacent 
segments, whereas 25 (59.5 %) occurred at distant levels, 
and another three (7.3 %) were the same.
PVP/PKP group
In terms of frequency of recompression, we selected a 
method similar to that of Dr Johannes et al. [8]. Fourteen 
(8.28 %) of these 169 patients developed 18 new OVCFs, 
three (21.4 %) of the 14 patients had a third compression 
fracture and a third PVP. Excluding the cervical spine as 
well as TH1–TH2 segments due to low risk of OVCFs, the 
other 15 levels (TH3–L5) were considered to occur new 
fracture(s) potentially. In the PVP/PKP group, 217 bodies 
were intervened initially and 18 (0.71 %) of the whole 2,535 
levels (169 patients × 15 vertebrae) developed new OVCFs, 
nine of them belonged to adjacent segments, the other nine 
belonged to distant segments, none of the pretreated seg-
ments recollapsed. Of these 2,318 (2,535–217) vertebral 
bodies, 360 (15.5 %) were adjacent to pretreated segments, 
while 1,958 levels came from the distant. Therefore, the per-
centages of new adjacent/distant OVCFs were 2.5 % (9/360) 
and 0.46 % (9/1,958) for the second compression fractures 
(χ2 = 16.4, p = 0.00). For the third new OVCFs, the data 
were 5.12 and 1.53 %, respectively (p = 0.239). Adjacent 
fractures were more prevalent than distant ones for the sec-
ond fractures; however, the differences had not reached 
statistical significance for the third-time fractures. Of the 
18 new fracture segments, ten new fracture segments were 
from levels above the pretreated segments, the other eight 
were from levels below the pretreated segments, and no 
refracture of pretreated segments was detected. The distance 
from the initial fracture segment in distant group was 2, 2, 
2, 2, 3, 3, 4, 7, 7 level(s), respectively. Calculated by patient 
number, six patients had new adjacent fractures and the 
other six was from nonadjacent cluster, with two patients 
experienced both adjacent and non-adjacent fractures.
The mean age of the 155 patients was 70.9 years, a lit-
tle younger than the refracture unit (73.1 ± 8.93, t = 1.974, 
p = 0.43). Males comprised 31.6 % (51 cases), and in the 
refracture group it was 35.7 % (5 cases, p = 1.00).
The distribution of original and new OVCFs is shown 
in Table 2. New fracture(s) occurred mostly in the thoracic 
and thoracolumbar segment compared with the previous 
fracture(s), but difference was not statistically significant 
(t = 2.11, p = 1.00).
The time interval was 8.95 ± 7.34 months for adjacent 
group and 10.75 ± 8.68 months for nonadjacent group. 
It seems that adjacent new OVCFs occurred earlier than 
nonadjacent levels; however, we did not find a statisti-
cally significant difference (t = 1.548, p > 0.05). Of the 
three patients that experienced third OVCFs,the symptom-
free interval after a second compression fracture was 6, 
2 months for adjacent segments and 15 months for a patient 
in the same treated segment. Owing to limited number of 
third fracture cases, we could not compare the data effec-
tively (Fig. 2).
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Table 1  Baseline clinical 
features of 31 patients who 
experienced new OVCF
CT conservative therapy, n.a. 
not applicable
Age Gender Level(s) of 
initial OVCFs
Time interval of 
recompression






65 M L1 23 months T11T12 PVP 4
76 M L1 L2 11 months T11T12 PVP 4.5 3
89 M L2 L3 9 months L1L4 PVP 3 3
79 M L2 9 months L1 PVP 3.5
53 F T7 23 months L2 PVP 4
65 F T11 3 months L1L2 PVP 3.5
76 F T12 16 months L1 PVP 6
76 F L2 1 months L1 PVP 5
79 F T5 T6 T7 2 months L2 PVP 1 1 1
75 F L2 22 months T12 PKP 5
73 M T10–L2 10 months T6 PKP 2.5 3 2 5 1.5
79 F T7 2 months T8 PKP 1
78 F L1 20 days T12 PKP 5
60 F L1 4.5 months L4 PKP 3
72 F L1 34 months T12 CT n.a.
79 F L1 26 months T12 CT n.a.
76 M T6 26 months T5 CT n.a.
66 M T9 T12 L1 L3 12 months L1 CT n.a.
49 M T12 72 months L1 CT n.a.
63 M L4 L5 8 months L2T12 CT n.a.
77 M T10 20 days T12 CT n.a.
63 M T8 7.5 months L1 CT n.a.
61 M T6 32 months L2 CT n.a.
79 F T8 36 months T12 CT n.a.
75 F T11 24 months L2 CT n.a.
74 F T9 36 months T12 CT n.a.
65 F T8 10 months L1L2L5 CT n.a.
72 F T9 5 months T9-12 CT n.a.
54 F L4 L5 12 months T10 CT n.a.
79 F T12 L2–4 48 months T6T9 CT n.a.
78 F L1 L3 5 months L1 CT n.a.









T3–T7 13 (5.99 %) 1 (5.56 %) 10 (6.85 %) 2 (8.33 %)
T8–T10 15 (6.92 %) 1 (5.56 %) 20 (13.7 %) 5 (20.8 %)
T11 14 (6.45 %) 2 (11.11 %) 11 (7.53 %) 1 (4.16 %)
T12 39 (17.97 %) 4 (22.22 %) 24 (16.5 %) 6 (25.0 %)
L1 60 (27.65 %) 5 (27.77 %) 35 (23.9 %) 5 (20.8 %)
L2 37 (17.05 %) 3 (16.67 %) 23 (15.75 %) 4 (16.7 %)
L3 17 (7.84 %) 0 (0 %) 6 (4.11 %) 0 (0 %)
L4 16 (7.37 %) 2 (11.11 %) 9 (6.17 %) 0 (0 %)
L5 6 (2.76 %) 0 (0 %) 8 (5.49 %) 1 (4.16 %)
Sum 217 18 146 24
Fig. 2  New OVCFs occurred sooner after PVP/PKP than after con-
servative treatment. Same level refractures received conservative 
treatment occurred much sooner than any other units
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The mean number of preexisting fractures in single time 
fracture group was 1.36 (1.36 ± 0.75, 95 %CI, 1.24–1.47) 
and in repeated fracture group, 1.57 (1.57 ± 1.11, 95 %CI, 
0.92–2.21). As can be seen from the above, baseline num-
ber of vertebra fracture is not a predictor for new fractures 
(t = 1.972, p > 0.05). The amount of injected cement was 
3.95 ± 1.43 (range 1.5–9 mL) in single time fracture group 
and 3.26 ± 1.54 (range 1–6 mL) in the repeated fracture 
group. There was no positive association between the quan-
tity and recollapse of new segment (t = 1.4651, p > 0.05).
PMMA leakage was observed in four cases (1.77 %) 
after the first incident: two into the disk, one into the lat-
eral blood plexus and one with anterior extravasation going 
up the above level (Fig. 1b T11). None of the leaks exuded 
into neural canal or caused neurologic symptoms. None of 
the patients developed refracture.
Conservative group
During the same follow-up period, 17 (14.0 %) of the 121 
patients went through 24 (24/1, 815,1.32 %) new OVCFs, 
two (11.7 %) developed a third compression fracture and a 
third PKP. Five segments belonged to adjacent section, 16 
from nonadjacent ones, and the remaining 3 from the same 
previous fracture segments. Using the same calculating 
method with PVP/PKP group, the proportion of adjacent 
new fractures (1.91 %, 5/261) is also higher than nonadja-
cent fractures (1.13 %, 16/1,408), but did not reach statisti-
cal significance (χ2 = 0.519, p = 0.471). Eight segments 
occurred above pretreated levels; thirteen from below sites, 
while 3 were from the same segments.
As the number of third fracture was limited, it was diffi-
cult to monitor the relative risk of new fractures sufficiently. 
With the accretion of distance from the original fracture 
level, recompression incidence decreased gradually. The 
mean time interval was 22.4 ± 7.99 months (range 0.67–
72 months). It seems that fracture occurrence in adjacent 
segments was more delayed than nonadjacent segments 
(28 ± 3.46 versus 18.8 ± 14.3 months);however, the data 
had not reached statistical significance.(t = 1.361, p > 0.05). 
The original and new OVCFs group also did not differ sig-
nificantly in age, gender distribution, location of original 
fracture segments, and number of preexisting fractures.
Comparison between PVP/PKP group and conservative 
group
We exclusively compared the data of second refractures 
due to only a minority of third recompressions. From our 
data, incidence of recompression in the conservative group 
is higher than that in the PVP/PKP group, with 14.05 % 
compared with 8.28 % concerning patient proportion and 
1.32 % compared with 0.71 % regarding refracture number. 
The relative risk is 1.69, but no statistical significance has 
been reached (χ2 = 2.455, p = 0.117). Both groups indi-
cate a higher incidence of adjacent recompression; how-
ever, the relative risk in PVP/PKP group (2.5 %, 9/360) 
is not significantly higher than that in conservative group 
(1.91 %, 5/261, p = 0.628).
Most of the second fractures in the PVP/PKP group 
occurred within the first year (71.42 %) compared with 
less than half of the recompression in the conservative 
group (47.05 %),and the mean interval was also much 
shorter in PVP/PKP group (9.72 ± 17.8 months) than 
that in the conservative group (22.48 ± 7.99 months, 
p = 0.017). Adjacent and nonadjacent new OVCFs of 
PVP/PKP group also occurred remarkably sooner than in 
the counterparts of conservative group. No major differ-
ences were observed in other parameters as presented in 
Table 3.
After the initial treatment, a total of 27 sandwich situ-
ations were created in both groups, no sandwich frac-
ture was observed in our follow-up period. Time inter-
val distinction between above and below levels after 
PMMA injection also did not reach statistical sig-
nificance (10.71 ± 7.74 versus 8.5 ± 7.53 months, 
p = 0.62), so did conservative therapy (25.6 ± 13.3 versus 
20.0 ± 11.7 months, p = 0.45).
Discussion
A total of 1.5 million new fractures, nearly half of which 
are vertebral (700,000), are reported in the US each year, 
outnumbering fractures of the hip and ankle combined. 
Patients with osteoporotic vertebral compression fractures 
often suffer from acute episodes of pain, increased mor-
bidity, prolonged hospitalization as well as long-term dis-
ability, as the natural healing history of OVCFs is often 
accompanied by 1–3 months bedrest. Also, the risk of pain 
and disability increases progressively with the number 
and severity of vertebral deformities. They are not typi-
cally associated with neurological deficit, since the frac-
tures do not extend into the spinal canal nor compress the 
neural elements. Generally, acute pain resolves in 4 weeks 
to 8 months. In the years before PVP/PKP invention, con-
servative management of OVCFs consists of bed rest, anal-
gesic medications, bracing, and physical therapy. However, 
some patients do not respond to these therapies in either 
terms of pain relief or progression of deformity. Long-term 
staying in bed can also bring out a series of complications, 
such as pneumonia, anorexia, indigestion, malnutrition, 
even stroke. An ideal therapy should both address frac-
ture-related pain and avoid the associated complications 
in a minimally invasive fashion. Since 1990s, PVP/PKP 
had become standard procedures for OVCFs regarding 
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Table 3  Baseline characteristics of patients in PVP/PKP group and conservative group





No (patients) 155 14 104 17 n.a. n.a. n.a.
Age, mean ± SD 
(range)
70.9 ± 10.04 (43–97) 73.1 ± 8.93 (53–89) 63.9 ± 15.51 (11–92) 69.5 ± 8.92 (49–79) 0.43 0.159 n.a.
Sex, female (%) 104 (68.4 %) 9 (64.2 %) 58 (55.7 %) 10 (58.8 %) 1.00 0.814 n.a.
Original fracture site (vertebrae)
 Thoracic spine 71 (36.6 %) 10 (43.4 %) 52 (43.3 %) 13 (50 %) 0.519 0.535 n.a.
 Lumbar spine 123 (63.4 %) 13 (56.6 %) 68 (56.7 %) 13 (50 %)
 Amount of bone 
cement
3.95 ± 1.43 (range 
1.5–9 mL)
3.26 ± 1.54 (range 
1–6 mL)
n.a. n.a. 0.22 n.a. n.a.
 PMMA leakage 3 cases n.a. n.a. n.a. n.a. n.a. n.a.
Number of previous fracture
 Mean 1.36 ± 0.75 1.57 ± 1.11 1.20 ± 0.46 1.53 ± 0.97 0.23 0.21 n.a.
 One 130 9 86 12
 Two 15 3 15 3
 Three 6 1 3 0
 Four 4 0 0 2
 Five 0 1 0 0
Distribution of new OVCFs
 Total n.a. 18 (0.71 %) n.a. 24 (1.32 %) n.a. n.a. 0.042
 Adjacent n.a. 9 (2.5 %) n.a. 5 (1.91 %) n.a. n.a. 0.117
 Between n.a. n.a. n.a. n.a. n.a. n.a. n.a.
 Distant n.a. 9 (0.46 %) n.a. 16 (1.13 %) n.a. n.a. 0.025
 Same n.a. n.a. n.a. 3 (2.05 %) n.a. n.a. n.a.
 Below n.a. 8 n.a. 13 n.a. n.a. n.a.
 Above n.a. 10 n.a. 8 n.a. n.a. n.a.
Incidence (patients)
 Total n.a. 14 (8.28 %) n.a. 17 (14.05 %) n.a. n.a. 0.117
 Adjacent n.a. 8 (4.73 %) n.a. 5 (4.13 %) n.a. n.a. 0.903
 Distant n.a. 8 (4.73 %) n.a. 11 (9.09 %) n.a. n.a. 0.130
 Same n.a. n.a. n.a. 3 (2.48 %) n.a. n.a. n.a.
Distance from the original fracture site
 One level n.a. 9 n.a. 5 n.a. n.a. n.a.
 Two levels n.a. 4 n.a. 4 n.a. n.a. n.a.
 Three levels n.a. 2 n.a. 4 n.a. n.a. n.a.
 Four levels n.a. 1 n.a. 2 n.a. n.a. n.a.
 Five levels n.a. 0 n.a. 2 n.a. n.a. n.a.
 Six levels n.a. 0 n.a. 2 n.a. n.a. n.a.
 Seven levels n.a. 2 n.a. 1 n.a. n.a. n.a.
 Eight levels n.a. n.a. n.a. 1 n.a. n.a. n.a.
Time interval 
(months)
n.a. 9.72 ± 17.8 n.a. 22.4 ± 7.99 n.a. n.a. 0.017
Adjacent n.a. 8.95 ± 7.34 n.a. 28 ± 3.46 n.a. n.a. 0.0002
Distant n.a. 10.75 ± 8.68 n.a. 18.8 ± 14.3 n.a. n.a. 0.255
Same n.a. n.a. n.a. 7.33 ± 3.29 n.a. n.a. n.a.
Above n.a. 10.71 ± 7.74 n.a. 25.6 ± 13.3 n.a. n.a. 0.031
Below n.a. 8.5 ± 7.53 n.a. 20.0 ± 11.7 n.a. n.a. 0.058
Access
 Unilateral 213 23 n.a. n.a. n.a. n.a. n.a.
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effective pain reduction and relatively low incidence of 
complications. But recently, many clinical investigations 
have reported an increased fracture risk of adjacent levels. 
Hulme et al. [9] reviewed 69 clinical series evaluating both 
kyphoplasty and vertebroplasty: 766 patients after PKP had 
115 new fractures and 66 % were located at adjacent levels. 
Mazzantini et al. [10] found a 27.8 % cumulative incidence 
of new vertebral fractures in a cohort of 115 patients treated 
with PVP after a follow-up of mean 39 months; 68 % 
occurred next to pretreated segments. Tseng et al. [11] 
investigated 852 patients (1,131 vertebrae),141 patients 
(16.6 %) after PVP experienced new OVCFs, 58.8–63.8 % 
of which were adjacent fractures. Similarly, Trout et al. 
[12] also reported a significant increase (41.4 %) in the 
incidence of fractures in the vicinity of cemented vertebrae 
on evaluation of 432 patients.
Unfortunately, much of the current literature reports 
their studies comparing original fractures and new frac-
tures mainly in operative group, there are only several 
limited data with respect to recompression incidence of 
PVP/PKP versus conservative treatment. Rikke et al. [13] 
reported that the relative risk for all new fractures in the 
PVP group compared with the conservative group was 2.9 
after 3 months and 1.3 after 12 months. However, Klazen 
et al. [14] observed 202 patients; there was no difference 
between PVP and conservative therapy.
In the current study, we found a similar incidence of rec-
ompression comparing PVP/PKP (8.28 %) with conserva-
tive therapy (14.0 %) on accordance of patient number, 
which is coincident with Klazen’s conclusion. From the 
standpoint of vertebrae, adjacent recompression occurred 
more frequently than distant levels and decreased gradually 
with the accretion of intervals in the PKP/PVP group. By 
contrast, no higher incidence of recompression in adjacent 
levels was observed in the conservative group. Prospec-
tive and retrospective studies reported an incidence of new 
fractures of 12.5–36.8 % after PVP/PKP [10, 15, 16]; our 
data seem to be favorable and could be the consequence 
of long-term compliance. In addition, we only registered 
symptomatic fractures, whereas in most of higher rate 
reports recompression was defined by imaging follow-
up. Moreover, in our experience, we intended to only fill 
the cavity left by the balloon or the fracture fissure rather 
than augment the entire vertebral body. Most patients fol-
lowed our guidelines for anti-osteoporosis therapy, which 
may also interpret the difference in refracture ratio. Tani-
gawa et al. [16] reported that 56 new OVCFs occurred in 
28 (36.8 %) of 76 patients after PVP, and 38 (67.8 %) of 
these fractures occurred in adjacent levels, more than half 
occurred within 3 months.
The exact mechanism for recompression is still unclear; 
several authors had published their clinical and biomechan-
ical investigations. Most of them indicate that load trans-
fer mechanism after augmentation is remarkably changed 
with increased stresses and strains in the levels of vicinity. 
Michael et al. [17] found the depression of the fractured 
endplate altered the pressure profile of the damaged disk 
resulting in increased compressive loading of the ante-
rior wall of adjacent vertebra that predisposed it to wedge 
fracture. Rohlmann et al. [18] also suggest that a wedge-
shaped fracture increases the flexion bending moment due 
to the upper body weight and thus a higher muscle force in 
the erector spinae is required to balance the spine, which 
results in a higher spinal load and a higher intradiscal pres-
sure. The erector spinae is a long muscle and thus its force 
affects intradiscal pressure not only at adjacent levels but 
also the whole region. Our findings agreed with this con-
tention for the location of refracture body all residing in the 
vicinity of eight levels. Viewed from this point, kyphop-
lasty may be an ideal alternative method in preventing 
further collapse compared with vertebroplasty for its rec-
tification of kyphotic deformity. In this study, we observed 
that refracture incidence in PKP group is lower than that in 
PVP group and the conservative group (6.33 versus 10 %, 
14.05 %, p = 0.426, 0.088), but not significantly. Most 
clinical and basic findings [19–21] asserted that the rate of 
developing new fractures was not strongly influenced by 
the volume of cement injected, as in the present study the 
P1 for the difference between single time fracture group and multifracture group after PVP/PKP
P2 for the difference between single time fracture group and multifracture group after conservative treatment
P3 for the difference in refracture group between PVP/PKP and conservative treatment
n.a. not applicable
Table 3  continued





 Bilateral 4 0 n.a. n.a. n.a. n.a. n.a.
Procedure
 PKP 79 5 (6.33 %) n.a. n.a. n.a. n.a. n.a.
 PVP 90 9 (10 %) n.a. n.a. n.a. n.a. n.a.
29Arch Orthop Trauma Surg (2014) 134:21–30 
1 3
average amount of initial bone cement is similar between 
single time fracture unit and refracture unit in the PVP/PKP 
group (3.95 ± 1.43 versus 3.26 ± 1.54 mL, p = 0.22).
In our current report, the rate of refracture concerning 
adjacent bodies is truly significantly higher than distant 
ones in PVP/PKP group (2.5 versus 0.46 %, p = 0.000), but 
the difference is not conspicuous in the conservative group 
(1.91 versus 1.13 %, p = 0.471). Nevertheless, the uni-
tary potentiality in the PVP/PKP group is inversely lower 
than in the conservative group (0.71 % versus 1.32 %, 
p = 0.042) from the standpoint of vertebrae. From these 
data we can extrapolate that both previous fracture and 
cement injection procedure increase the risk of new adja-
cent fractures, but cement injection procedure increases the 
risk more significantly. However, the odds is relatively low 
and has no significant differences compared with conserva-
tive treatment (2.5 versus 1.91 %, p = 0.636). Therefore, 
patients who experienced PVP/PKP may have a relatively 
low risk of developing new fractures, not to mention its 
immediate pain relief, early mobilization, and other short-
term benefits.
The timing of postoperative OVCFs in our study also 
seems to be more favorable than that in prior studies, which 
have shown that between 43 and 67 % of subsequent inci-
dent fractures occur within 3 months. In the PVP/PKP 
group, 71.42 % of the second fractures take place within 
the first year, while only 47.05 % of the second fractures in 
the conservative group do in the same period. Mean interval 
was much shorter in PVP/PKP group (9.72 ± 17.8 months) 
than in conservative group (22.48 ± 7.99 months, 
p = 0.017). Both Tseng et al. [11] and Trout et al. [12] 
asserted that adjacent fractures emerged sooner than distant 
levels following cement injection. The period from a fresh 
compression fracture to the first adjacent compression frac-
ture was 78.2 ± 97.1 days and to the first distant compres-
sion fracture was 231.9 ± 224.6 days according to Tseng 
et al. While in our clinical follow-up a similar result was 
observed in the PVP/PKP group, the data are 8.95 ± 7.34 
and 10.75 ± 8.68 months, respectively (p < 0.05). For con-
servative treatment, the new adjacent segments occurred 
even more delayed than nonadjacent segments although no 
statistical discrepancy has been reached (28 ± 3.46 versus 
18.8 ± 14.3 months, p > 0.05). So we can hypothesize that 
cement injection may precipitate the refracture, particularly 
to adjacent segments.
No same level refracture was observed following 
PVP/PKP, while in conservative group, the refracture rate 
was relatively high (2.05 %) and occurred sooner than 
that in any other unit (7.33 ± 3.29 months). Thus usage 
of operation procedure may be advantageous in holding 
back further refracture of the same segment. However, even 
cemented vertebrae refracture occasionally, Lin et al. [6] 
reported an incidence of 63 % in their retrospective clinical 
analysis, and concluded that significant anterior vertebral 
height restoration increases the risk of subsequent fracture 
after vertebroplasty. This conclusion challenges some theo-
ries we have discussed above; one problem is how to guar-
antee enough kyphotic angle rectification on the one hand 
while avoiding greater anterior vertebral height restoration 
on the other.
Johannes et al. [8] demonstrated a remarkable propen-
sity of refractures within three levels above or below preex-
isting fractures. From our data, we got a similar outcome; 
83.3 % of new OVCFs in PVP/PKP group and 56.2 % in 
conservative group support this interpretation. The loca-
tions in thoracolumbar segments where original fractures 
distributed in are prone to refracture both after PMMA 
injection and conservative therapy. New fractures tend to 
occur more frequently in thoracic vertebrae in both groups 
but no conspicuous discrepancy. The issue of multitime 
fractures (>2) after PVP has been raised and analyzed to 
some extent by Tseng et al. [11]. In our study these data 
were so limited and, therefore, could not be compared.
Another risk factor of new fractures of adjacent vertebral 
bodies is cement leakage into the disk. Pitton et al. [22] 
studied 191 patients in whom 385 vertebroplasties were 
performed. The overall rate of cement leaks was 55.6 %, 
including all leaks detectable by CT. Ten of 30 adjacent 
fractures occurred in the presence of preexisting intradiscal 
cement leaks and six belonged to 11 sandwich fractures of 
29 sandwich situations after mean 1.5 months. However, in 
three cases (1.77 %) cement leakage occurred during oper-
ation in our institution and none developed refracture. In 
the meantime, no sandwich fracture was observed in a total 
of 27 sandwich situations in both groups. Pitton et al. iden-
tified that the sandwich situation changed the contextual 
environment because of the stiffening and the loss of ver-
tical elasticity of the two proximate vertebrae but was not 
associated with an increased secondary fracture rate. Our 
data support their viewpoint, yet no evidence is available 
until now. Further researches are needed to focus on this 
specific constellation. In addition, older age, gender, frac-
ture times, operation modality (PVP or PKP), and initial 
number of OVCFs were also documented, but they were 
not the influencing factors in developing new symptomatic 
OVCFs in this study.
We selected a calculating method similar to that of 
Johannes et al. [8], in which adjacent and nonadjacent 
segments were divided, because the total number of adja-
cent vertebrae generated by first time fracture is relatively 
small compared with that of distant levels. As a result, only 
simply computing the incidence of adjacent refractures by 
dividing the sum number of new OVCFs cannot reflect the 
condition practically. However, if count the refracture inci-
dence by simply calculating the patient number, the above 
two therapeutics could bring out similar results.
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Some issues remain unanswered even in the current 
study. We discussed the effects of PVP/PKP and conserva-
tive therapy only clinically, not biomechanically, and long-
term effects are still unknown. Furthermore, whether resort 
to cement injection or let it alone in terms of sandwich situ-
ation is not known. Therefore, further research using larger 
patient populations and in vitro experiment may help to 
resolve the unclear results concerning this study. Moreover, 
the results of this study need to be confirmed by additional 
high-quality RCT clinical studies.
Conclusions
From most data reported in the literatures, the risk of expe-
riencing new OVCFs increased after PVP/PKP. However, 
in this prospective study, compared with conservative 
therapy, patients who had experienced PVP/PKP were not 
associated with an increased risk of recompression in new 
levels with a mean 49.4-month follow-up period. But one 
point that new OVCFs occurred sooner after cement injec-
tion than that after conservative treatment must be taken 
into consideration. The presence of sandwich situation is 
not associated with an increased secondary fracture rate 
and no interrelated factor has been confirmed to be influen-
tial ingredient for subsequent fractures. Existing fractures 
are strong independent predictors of the risk of future ver-
tebral fractures so we tend to believe that it is more of a 
natural process other than induced by PVP/PKP.
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